SG Capital Management LLC Invests $8.14 Million in Ralliant Corporation $RAL

SG Capital Management LLC bought a new position in shares of Ralliant Corporation (NYSE:RAL) in the third quarter, Holdings Channel reports. The firm bought 186,120 shares of the company’s stock, valued at approximately $8,139,000.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in Ralliant by 10.7% during the third quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after buying an additional 1,415,327 shares in the last quarter. Fifth Third Bancorp acquired a new position in shares of Ralliant during the 3rd quarter valued at $124,000. State of New Jersey Common Pension Fund D boosted its position in Ralliant by 37.7% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 50,681 shares of the company’s stock worth $2,216,000 after purchasing an additional 13,871 shares during the period. PNC Financial Services Group Inc. increased its holdings in Ralliant by 4.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 47,027 shares of the company’s stock valued at $2,057,000 after purchasing an additional 2,126 shares in the last quarter. Finally, Public Sector Pension Investment Board raised its position in Ralliant by 14.4% in the third quarter. Public Sector Pension Investment Board now owns 439,714 shares of the company’s stock valued at $19,229,000 after purchasing an additional 55,237 shares during the period.

Analysts Set New Price Targets

Several analysts have issued reports on RAL shares. Weiss Ratings downgraded shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research report on Thursday, February 5th. Vertical Research raised shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target on the stock in a research note on Friday, February 6th. Zacks Research cut shares of Ralliant from a “hold” rating to a “strong sell” rating in a research report on Monday, February 9th. Citigroup lowered their target price on Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a research note on Friday, February 6th. Finally, Truist Financial cut their price target on Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Ralliant has a consensus rating of “Hold” and an average price target of $50.50.

Ralliant News Summary

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Management reiterated outlook and highlighted share buybacks at recent conferences, which could support earnings per share over time and signal capital return discipline. Ralliant Highlights Outlook and Share Buybacks at Conferences
• Neutral Sentiment: Ralliant presented at the Barclays Industrial Select Conference (slides made public) — informational for investors but not materially new versus the company’s prior guidance. Ralliant Presents at Barclays Conference
• Negative Sentiment: Multiple law firms (Kaplan Fox, Schall, Kessler Topaz, Levi & Korsinsky) have announced investigations into Ralliant for potential securities-law violations or fraud tied to disclosures around the quarter. These actions increase legal risk, create potential follow‑on litigation and regulatory scrutiny, and are a major near‑term overhang on the stock. Kaplan Fox Investigation Alert Schall Law Firm Notice Kessler Topaz Notice
• Negative Sentiment: Levi & Korsinsky flagged a roughly $14-per-share divergence between adjusted EPS (which beat estimates) and GAAP EPS (a $12.10 loss), driven mainly by a $1.4 billion goodwill impairment disclosed in the Feb. 4 release. That accounting shock raises questions about prior impairment assessment, earnings quality, and management disclosure — the proximate cause of the investor and media scrutiny. Levi & Korsinsky Probe
• Negative Sentiment: Media coverage (local and national) is highlighting the size of the charge and the resulting fraud/probe headlines; negative press can amplify volatility and pressure the stock until legal or accounting issues are resolved. Hoodline Coverage

Insider Transactions at Ralliant

In other Ralliant news, Director Anelise Angelino Sacks bought 2,000 shares of the company’s stock in a transaction on Monday, February 9th. The shares were bought at an average cost of $41.25 per share, with a total value of $82,500.00. Following the completion of the acquisition, the director owned 5,403 shares of the company’s stock, valued at approximately $222,873.75. This trade represents a 58.77% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kate Mitchell purchased 2,350 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was acquired at an average cost of $42.48 per share, with a total value of $99,828.00. Following the completion of the acquisition, the director directly owned 8,411 shares in the company, valued at approximately $357,299.28. This trade represents a 38.77% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 8,145 shares of company stock valued at $332,233 over the last 90 days.

Ralliant Trading Down 1.2%

NYSE RAL opened at $43.98 on Thursday. The company has a market capitalization of $4.96 billion and a price-to-earnings ratio of 22.44. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $57.02. The company’s fifty day moving average price is $50.36 and its two-hundred day moving average price is $46.52.

Ralliant (NYSE:RAL) last issued its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. The business’s revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, March 9th. Ralliant’s payout ratio is 10.20%.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.